Back to search results

Exercise Intervention for Anxiety Disorders

This study is looking at how exercise might help people with anxiety disorders. Researchers want to understand the biological changes in the brain that happen when someone exercises, specifically how exercise affects brain markers related to energy (acetyl-L-carnitine or LAC) and inflammation (interleukin-6 or IL-6). You could be eligible if you are between 18 and 50 years old, currently don't exercise much, and are willing to give informed consent. The study is testing an Exercise Intervention delivered virtually in weekly sessions over four weeks. The main goal is to see how LAC and IL-6 levels change after these four weeks of exercise. The current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 30 participants. It is not specified if it is randomized or blinded.
What's involved
You would participate in weekly virtual exercise sessions for four weeks, each lasting 25-45 minutes. These sessions involve reviewing your exercise, planning for the next week, and discussing challenges.
Compensation
Not stated in the trial record.
Follow-up
Researchers will measure brain markers at Week 4, which is the end of the intervention period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07340281

Biomarkers for Exercise

Recruiting
NAAges 18–50InterventionalBasic science
NYU Langone Health
~30 participants
Updated 2026-03-31 on ClinicalTrials.gov
What's tested:Exercise Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acetyl-L-carnitine (LAC) Levels
Measured over Week 4
+1 more outcome measured

Conditions

Anxiety Disorders

Explore related trials

Anxiety Disorder

NCT07340281

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • NYU Langone Health

    New York, New Yorkno site contact published

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Kristin Szuhany, PhD · PRINCIPAL_INVESTIGATOR · NYU Langone Health

Who to contact

Kristin Szuhany, PhD
[email protected]
646-754-5161
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Between 18-50 years of age
Currently sedentary (≤60 minutes of moderate intensity exercise per week for the past 3 months)
Capable and willing to provide informed consent

Exclusion

Lifetime history of Bipolar I or II or any psychotic disorder
Bulimia or anorexia in the past 3 months
Alcohol or substance use disorder in the past 3 months
Current major depressive disorder (past is allowed)
Current neurologic disorder
High current suicide risk (active suicidal ideation with plan and intent) as indicated by a score of ≥4 on the Columbia Suicide Severity Rating Scale (C-SSRS) consistent with a need for referral to higher level of care
Participation in concurrent evidence-based therapy (e.g., cognitive behavioral therapy) targeting anxiety and/or depression (supportive therapy and couples therapy are allowed)
Risk for exercise according to the Physical Activity Readiness Questionnaire with excluded active medical conditions including heart conditions, lung disease, bone/joint problems, or seizures
Women who are currently pregnant or plan to become pregnant during the duration of the study
current psychiatric medication
Current substance abuse or positive urine toxicology screen (recreational use of marijuana is permitted based on clinical assessment on the MINI structured diagnostic interview that it does not meet criteria for cannabis use disorder)
Active infection

What this trial measures

  • Acetyl-L-carnitine (LAC) LevelsWeek 4

    Levels of LAC isolated from neuronal exosomes from plasma blood draws.

  • Interleukin-6 (IL-6) LevelsWeek 4

    Levels of IL-6 isolated from neuronal exosomes from plasma blood draws.